Study to Evaluate Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

306

Participants

Timeline

Start Date

May 17, 2022

Primary Completion Date

September 9, 2024

Study Completion Date

September 9, 2024

Conditions
Asthma
Interventions
BIOLOGICAL

Tezepelumab

Tezepelumab subcutaneous injection

Trial Locations (77)

1142

Research Site, Sofia

1200

Research Site, Brussels (Woluwé-St-Lambert)

1426

Research Site, CABA

1431

Research Site, Sofia

1629

Research Site, Pilar

1842

Research Site, Monte Grande

1886

Research Site, Ranelagh

1888

Research Site, San Juan Bautista

2000

Research Site, Rosario

4000

Research Site, San Miguel de Tucumán

Research Site, Liège

5000

Research Site, Sofia

5101

Research Site, Erpent

5250

Research Site, Velika Tarnovo

6305

Research Site, Haskovo

7200

Research Site, Razgrad

8035

Research Site, Barcelona

9000

Research Site, Ghent

10467

Research Site, The Bronx

12203

Research Site, Berlin

13915

Research Site, Marseille

15517

Research Site, Fürstenwalde

15801

Research Site, DuBois

19713

Research Site, Newark

23100

Research Site, Bychawa

23858

Research Site, Reinfeld (Holstein)

28041

Research Site, Madrid

29609

Research Site, Brest

31000

Research Site, Chihuahua City

31200

Research Site, Chihuahua City

33011

Research Site, Oviedo

33076

Research Site, Bordeaux

33470

Research Site, Loxahatchee Groves

38010

Research Site, Santa Cruz de Tenerife

39008

Research Site, Santander

41009

Research Site, Seville

44000

Research Site, Nantes

44100

Research Site, Guadalajara

48109

Research Site, Ann Arbor

55128

Research Site, Mainz

64283

Research Site, Darmstadt

64360

Research Site, Monterrey

69004

Research Site, Lyon

92160

Research Site, Antony

92663

Research Site, Newport Beach

08755

Research Site, Toms River

C1121ABE

Research Site, Buenos Aires

C1012AAR

Research Site, CABA

M5500GHB

Research Site, Mendoza

B1878FNR

Research Site, Quilmes

B1646EBJ

Research Site, San Fernando

Unknown

Research Site, Montpellier

Research Site, LE3 9QP

06000

Research Site, Nice

LV-5410

Research Site, Daugavpils

LV-5417

Research Site, Daugavpils

LV-2015

Research Site, Jūrmala

LV-1011

Research Site, Riga

LV1002

Research Site, Riga

LV1010

Research Site, Riga

LV-4201

Research Site, Valmiera

26-020

Research Site, Chmielnik

80-952

Research Site, Gdansk

31-011

Research Site, Krakow

92-213

Research Site, Lodz

27-400

Research Site, Ostrowiec Świętokrzyski

41-200

Research Site, Sosnowiec

50-044

Research Site, Wroclaw

53-301

Research Site, Wroclaw

54-239

Research Site, Wroclaw

08916

Research Site, Badalona

BT97AB

Research Site, Belfast

BD9 6RJ

Research Site, Bradford

SE1 7EH

Research Site, London

SW3 6HP

Research Site, London

NG5 1PB

Research Site, Nottingham

PO6 3LY

Research Site, Portsmouth

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY